Bolt Biotherapeutics, Inc.
BOLT
Rank in Stocks
#28094
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting... Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indications such as colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody designed to reprogram crucial immune cells within the tumor microenvironment by interacting with macrophage cell-surface receptors. Bolt is also pursuing a programmed cell death-ligand 1 (PD-L1) initiative aimed at addressing tumors that prove resistant to existing immune checkpoint blockades. Incorporated in 2015 under its previous name, Bolt Therapeutics, Inc., before officially becoming Bolt Biotherapeutics, Inc. in July of the same year, the company maintains its corporate headquarters in Redwood City, California.
Share Price
$6.43
Last synced: 2026-11-09
Market Cap
$12.39M
Change (1 day)
-1.68%
Change (1 year)
33.68%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bolt Biotherapeutics, Inc. (BOLT)
Category
Healthcare
Dividend history for Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (stock symbol: BOLT) made a total of 11 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.83
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $0.83
Dividend yield (TTM) : 0.00%
Dividend payments for Bolt Biotherapeutics, Inc. (BOLT) from 2012 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.36 | 33.33% |
| 2014 | $0.27 | -15.63% |
| 2013 | $0.32 | 33.33% |
| 2012 | $0.24 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.018 | 33.33% |
| 2014 | $0.0135 | -15.63% |
| 2013 | $0.016 | 33.33% |
| 2012 | $0.012 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
Questions about Bolt Biotherapeutics, Inc.'s dividend per share
What is Bolt Biotherapeutics, Inc.'s dividend per share?
Bolt Biotherapeutics, Inc.'s dividend per share over the last twelve months is $0.36, as of Aug 2014.
What was Bolt Biotherapeutics, Inc.'s dividend per share in 2014?
In 2014, Bolt Biotherapeutics, Inc.'s dividend per share was $0.27, 15.63% less than in 2013 ($0.32).
How has Bolt Biotherapeutics, Inc.'s dividend per share changed since 2012?
From 2012 to 2014, Bolt Biotherapeutics, Inc.'s dividend per share went from $0.24 to $0.27, an average growth of 6.07% a year.